Overactive STAT3 Dysregulates BCR Signalling and Drives Accumulation and Autoreactivity of Disease-Associated CD21low B Cells
Year: 2025
Type: article
Abstract: Introduction Signal transducer and activator of transcription 3 (STAT3) regulates gene expression downstream of cytokine/hormone receptors. Germline heterozygous STAT3 gain-of-function mutations cause early-onset multi-organ autoimmune disease, including type-1 diabetes, autoimmune thyroid disease, rheumatoid arthritis, enteropathies, autoimmune cytopenias, and/or B memory lymphopenia, many pointing to B cell tolerance defects. In populations, JAK-STAT3 polymorphisms and STAT3 signalling cytokines are associated with increased risk of B cell-mediated autoimmune diseases, and the cytokines’ levels correlate with disease severity. Finally, STAT3 can be mutated to gain-of-function and is frequently constitutively active in B lymphomas. Despite this, B cell-intrinsic effects of overactive STAT3 remain unknown. Method and Results We address this in patients, and mice engineered to carry the most common pathogenic germline gain-of-function mutation, STAT3T716M, or STAT3G421R and STAT3K658N, also found in lymphomas/leukemias. Gain-of-function STAT3 causes aberrant accumulation of polyclonal CD21low B cells resembling those that accumulate with age, chronic infections, immunodeficiency, and autoimmune diseases. It causes accumulation of self-reactive SWHEL B cells recognising a blood cell surface autoantigen and, in humans, of VH4-34+ B cells recognising I/i self-antigen on blood cells. Using mouse and human BCR deep sequencing, flow cytometry, single-cell RNA, and chromatin immunoprecipitation sequencing, we show overactive STAT3 induces a surprising and striking dysregulation of BCR signalling molecules, many of which are direct pSTAT3 targets, and dysregulates BCR-induced Tbet and atypical differentiation. We use in vivo inhibition to test whether STAT3-mutant atypical B cells are specifically depleted by BCR-PI3K inhibition. In a first-in-kind analysis, we study additive effects of JAK-STAT3 and BCR polymorphisms on atypical B cell abundance and mRNA phenotypes in single-cell expression quantitative trait loci and RNA sequencing data from >1,000 individuals. Conclusion Our findings reveal the landscape of genes and proteins dysregulated by overactive STAT3 in B cells and a novel mechanism explaining over-accumulation of autoantibody-enriched CD21low B cells in multiple diseases characterised by JAK-STAT polymorphisms and/or over-abundant IL-6/IL-21 cytokines.
Source: Journal of Human Immunity
Authors: Etienne Masle-Farquhar, Timothy Peters, Katherine Jackson, Blake Bowen, Danielle Avery, Erica Schmitt, Christopher Jara, Ania Moxon, Joseph Mackie, Megan L. Faulks, Mandeep Singh, Anna Forster, Daniel Suan, Gulbu Uzel, Hassan Abolhassani, Ignatius Chua, Jennifer W Leiding, Kaarina Heiskanen, Kahn Preece, Leena Kainulainen, Michael O’Sullivan, Mikko Seppänen, Satu Mustjoki, Shannon Brothers, Tiphanie Vogel, Megan Cooper, Owen Siggs, Cindy Ma, Peter McNaughton, Robert Brink, Joseph Powell, Stuart Tangye, Joanne Reed, Christopher Goodnow
Institutions: Garvan Institute of Medical Research, UNSW Sydney, St. Louis Children's Hospital, Washington University in St. Louis, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Karolinska University Hospital, Karolinska Institutet, Canterbury Health Laboratories, Johns Hopkins University, University of South Florida, Johns Hopkins All Children's Hospital, University of Helsinki, Helsinki University Hospital, Christchurch Hospital, University of Turku, Turku University Hospital, Fiona Stanley Hospital, Fiona Stanley Fremantle Hospitals Group, Starship Children's Health, The University of Sydney, Westmead Institute for Medical Research
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W4416718509
FWCI:
Cites:
Cited by:
Related to: